Welcome to kongre.net
Speaker
Director, Voyager Therapeutics Inc
John Steele, Director at Voyager Therapeutics Inc, spoke at 6th iPSC Drug Development Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Fireside Chat: Balancing Immune Evasion with Safety Controls to Prevent Oncogenic Outgrowth & Improve Preclinical Risk Predictability”.
9–10 Sept 2026Boston, United States of America
Clinical Manufacturing Head, Cartherics Pty Ltd
Chief Scientific Officer, Logomix, Inc.
Head of Research & Development, Karis Bio
President & Chief Technology Officer, Cellistic
Chief Executive Officer & Co-Founder, Theseus Therapies
Vice President, Corporate Innovation, Catalent, Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by John Steele, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].